We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Methylphenidate Hydrochloride Extended-Release Capsules (LA) 60mg (Granules Pharmaceuticals Inc, USA)
Section 19A approved medicine
Methylphenidate Hydrochloride Extended-Release Capsules (LA) 60mg (Granules Pharmaceuticals Inc, USA)
Section 19A approval holder
Pharmacor Pty Ltd ABN 58 121 020 835
Phone
1300 138 805
Approved until
Status
Current
Medicines in short supply/unavailable
RITALIN LA methylphenidate hydrochloride 60mg modified release capsules bottle - ARTG 236251
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack - ARTG 362234
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack - ARTG 362234
Indication(s)
Methylphenidate hydrochloride modified release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Images
